Abstract: The present invention relates to methods of administering to a subject multimeric oligonucleotides having monomeric subunits joined by linkers. The multimeric oligonucleotides have a molecular weight of at least about 45 kD and other characteristics, such that their clearance due to glomerular filtration is reduced. The present invention also relates to such multimeric oligonucleotides and methods of synthesizing such multimeric oligonucleotides.

Abstract: Defined multi-conjugate oligonucleotides can have predetermined sizes and compositions. For example, in various embodiment, defined multi-conjugate oligonucleotides can have advantageous properties, for example in the form of defined multi-conjugate siRNA (i.e., including two, three or more siRNA) having enhanced intracellular delivery and/or multi-gene silencing effects. In various embodiment, the defined multi-conjugate oligonucleotides can be synthesized via new synthetic intermediates and methods. The defined multi-conjugate oligonucleotides can be used, for example, in reducing gene expression, biological research, treating or preventing medical conditions, or to produce new or altered phenotypes in cells or organisms.

Abstract: A system is provided for managing patent licenses. The system comprises at least one memory including a first memory location for storing a signal representing a plurality of patent licenses available for procurement. The system also comprises at least one network interface for receiving a signal from a user designating at least one of the licenses for procurement. The system furthermore comprises at least one processor for processing a procurement transaction by which the user procures the at least one designated license. The at least one memory further comprises a second memory location for storing a signal representing information pertinent to the procurement transaction including information regarding an identity of the user and information regarding the procured license.